Cullinan Oncology LLC (CGEM) Insider Trading
- $11,332,672.00
- $17,816,982.32
- Feb. 24, 2026
- Jennifer Michaelson
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 4, 2022 | Major Shareholder | 25,989 | $14.31 | Sell | $371,902.59 | |
| Aug. 2, 2022 | Major Shareholder | 4,792 | $14.10 | Sell | $67,567.20 | |
| July 25, 2022 | Insider | 8,000 | $14.51 | Sell | $116,080.00 | |
| July 18, 2022 | Insider | 5,042 | $15.06 | Sell | $75,932.52 | |
| July 11, 2022 | Acting Chief Business Officer | 39,800 | $13.33 | Sell | $530,534.00 | |
| June 23, 2022 | Major Shareholder | 29,631 | $13.00 | Sell | $385,203.00 | |
| June 21, 2022 | Major Shareholder | 22,319 | $12.77 | Sell | $285,013.63 | |
| June 6, 2022 | CEO | 8,090 | $12.40 | Buy | $100,316.00 | |
| June 1, 2022 | Major Shareholder | 751,396 | $11.00 | Buy | $8,265,356.00 | |
| May 16, 2022 | Major Shareholder | 35,158 | $11.23 | Sell | $394,824.34 | |
| May 12, 2022 | Major Shareholder | 264,072 | $9.25 | Sell | $2,442,666.00 | |
| April 1, 2022 | Major Shareholder | 276,000 | $10.75 | Buy | $2,967,000.00 | |
| Oct. 18, 2021 | Insider | 4,000 | $21.42 | Sell | $85,680.00 | |
| Oct. 15, 2021 | CFO | 8,000 | $25.00 | Sell | $200,000.00 | |
| Oct. 15, 2021 | Insider | 19,574 | $25.00 | Sell | $489,350.00 | |
| Oct. 7, 2021 | Insider | 1,079 | $25.00 | Sell | $26,975.00 | |
| Sept. 20, 2021 | Insider | 4,000 | $24.51 | Sell | $98,040.00 | |
| Sept. 15, 2021 | Director | 888 | $29.16 | Sell | $25,894.08 | |
| Sept. 15, 2021 | Major Shareholder | 6,425 | $29.16 | Sell | $187,353.00 | |
| Sept. 13, 2021 | Major Shareholder | 3,595 | $29.10 | Sell | $104,614.50 | |
| Sept. 13, 2021 | Director | 497 | $29.10 | Sell | $14,462.70 | |
| Sept. 9, 2021 | Director | 1,898 | $29.35 | Sell | $55,706.30 | |
| Sept. 9, 2021 | Major Shareholder | 13,727 | $29.35 | Sell | $402,887.45 | |
| Sept. 7, 2021 | Major Shareholder | 25,067 | $29.04 | Sell | $727,945.68 | |
| Sept. 7, 2021 | Insider | 28,118 | $28.95 | Sell | $814,016.10 | |
| Sept. 7, 2021 | Director | 3,465 | $29.04 | Sell | $100,623.60 | |
| Sept. 3, 2021 | Major Shareholder | 12,731 | $29.60 | Sell | $376,837.60 | |
| Sept. 3, 2021 | Director | 1,760 | $29.60 | Sell | $52,096.00 | |
| Sept. 1, 2021 | Major Shareholder | 5,714 | $29.47 | Sell | $168,391.58 | |
| Sept. 1, 2021 | Director | 790 | $29.47 | Sell | $23,281.30 | |
| Aug. 30, 2021 | Major Shareholder | 31,001 | $29.30 | Sell | $908,329.30 | |
| Aug. 30, 2021 | Director | 4,285 | $29.30 | Sell | $125,550.50 | |
| Aug. 27, 2021 | Major Shareholder | 13,357 | $29.09 | Sell | $388,555.13 | |
| Aug. 27, 2021 | Director | 1,846 | $29.09 | Sell | $53,700.14 | |
| Aug. 25, 2021 | Director | 237 | $29.09 | Sell | $6,894.33 | |
| Aug. 25, 2021 | Major Shareholder | 1,713 | $29.09 | Sell | $49,831.17 | |
| Aug. 23, 2021 | Director | 7,376 | $29.11 | Sell | $214,715.36 | |
| Aug. 23, 2021 | Major Shareholder | 53,359 | $29.11 | Sell | $1,553,280.49 | |
| Aug. 11, 2021 | Major Shareholder | 2,510 | $29.05 | Sell | $72,915.50 | |
| Aug. 11, 2021 | Director | 347 | $29.05 | Sell | $10,080.35 | |
| Aug. 9, 2021 | Insider | 21,204 | $26.57 | Sell | $563,390.28 |
Insiders are both buying and selling Cullinan Oncology LLC stock.
The insider traders at Cullinan Oncology LLC are: Jennifer Michaelson, Ansbert Gadicke, Oncology Impact Fund L.P. Ubs, Jeffrey Trigilio, Nadim Ahmed, Jeffrey Alan Jones, Corrine Savill, Leigh Zawel, Vision Scs F2, Jacquelyn L Sumer, Bvf Partners L P/Il, Bioscience I 2017 Ltd F2, Mary Kay Fenton, and Savill Corrine
The most active insider trader at Cullinan Oncology LLC is Jennifer Michaelson with 22 trades.
Oncology Impact Fund L.P. Ubs has sold the most Cullinan Oncology LLC stock with a total value of $5,128,294.40.
Bvf Partners L P/Il has bought the most Cullinan Oncology LLC stock with a total value of $19,497,712.00.
The most recent insider trade for Cullinan Oncology LLC was on Feb. 24, 2026.
The single biggest insider buy for Cullinan Oncology LLC was from Bvf Partners L P/Il with a total value of $8,265,356.00 on June 1, 2022.
The single biggest insider sell for Cullinan Oncology LLC was from Vision Scs F2 with a total value of $2,442,666.00 on May 12, 2022.
